Study on oxytocin to reduce bleeding during D&E
Part of Women’s health & pregnancy clinical trials.
This trial tests if giving oxytocin before a dilation and evacuation (D&E) procedure helps reduce bleeding. It may help people scheduled for a D&E at 18 weeks or later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a clinic-based D&E at 18 weeks or more of pregnancy
- You speak English or Spanish
- You are not using blood thinners (anticoagulants) in the last 5 days
- You do not have a bleeding disorder or infection in the uterus
- You are not using misoprostol for cervical preparation
- This is not for a pregnancy with multiple babies or fetal loss
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if a medicine called tranexamic acid (TXA) can help reduce bleeding during a second-trimester abortion or miscarriage procedure. The goal is to make the procedure safer for patients.
This trial tests a new under-the-tongue tablet (sublingual oxytocin) to prevent heavy bleeding after childbirth. It aims to see if it works safely in healthy women having a vaginal delivery at full term.
This study compares two ways of giving the medicine oxytocin (which helps the womb tighten to reduce bleeding) after a C-section in women at high risk for heavy bleeding. It will see if giving it as a single injection or as a slow drip works better at preventing excessive blood loss.
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
This study tests whether giving a medication (misoprostol) rectally during a planned C-section can help reduce blood loss after delivery. It may help women have a safer recovery with less bleeding.
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.